Drug · SMILES 확보 · 중간 유사도
Exploration Score · catalog ranks
Rule-based Catalog Exploration Score for pharmacophore cores and drug/derivative nodes. Not an efficacy prediction.
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.
Derivative structure exploration tiers · CNS
Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.
How similarity is calculated · How clustering works · How exploration priority is scored
치료 영역 · 계열
HighHigh exploration priority7
Highest Exploration Score percentile in this pool (X-S bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| High | Alprazolam Benzodiazepine GABA-A modulators · Drug | Anxiolytic · GABA | 61 | Drug · SMILES 확보 · 중간 유사도 | |
| High | Diazepam Benzodiazepine GABA-A modulators · Drug | Anxiolytic · GABA | 61 | Drug · SMILES 확보 · 중간 유사도 | |
| High | Sumatriptan Migraine triptan series · Drug | Migraine · triptan | 60 | Drug · SMILES 확보 · 중간 유사도 | |
| High | Zolmitriptan Migraine triptan series · Drug | Migraine · triptan | 60 | Drug · SMILES 확보 · 중간 유사도 | |
| High | Atogepant CGRP gepant migraine series · Drug | Migraine · CGRP gepant | 59 | Drug · SMILES 확보 · Core 유사 81% | |
| High | Midazolam Benzodiazepine GABA-A modulators · Drug | Anxiolytic · GABA | 59 | Drug · SMILES 확보 · 중간 유사도 | |
| High | Rizatriptan Migraine triptan series · Drug | Migraine · triptan | 59 | Drug · SMILES 확보 · 중간 유사도 |
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · Core 유사 81%
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
MedMedium exploration priority14
Upper-mid Exploration Score percentile (X-A bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| Med | Ubrogepant CGRP gepant migraine series · Drug | Migraine · CGRP gepant | 59 | Drug · SMILES 확보 · Core 유사 81% | |
| Med | Clonazepam Benzodiazepine GABA-A modulators · Drug | Anxiolytic · GABA | 57 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Eletriptan Migraine triptan series · Drug | Migraine · triptan | 57 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Lorazepam Benzodiazepine GABA-A modulators · Drug | Anxiolytic · GABA | 57 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Naratriptan Migraine triptan series · Drug | Migraine · triptan | 57 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Carbidopa Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 56 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Levodopa Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 56 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Amphetamine ADHD stimulant / non-stimulant series · Drug | ADHD | 54 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Lisdexamfetamine ADHD stimulant / non-stimulant series · Drug | ADHD | 54 | Drug · SMILES 확보 · 중간 유사도 | |
| Med | Quetiapine Atypical antipsychotic series · Drug | Antipsychotic | 51 | Drug · SMILES 확보 | |
| Med | Safinamide Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 51 | Drug · SMILES 확보 | |
| Med | Atomoxetine ADHD stimulant / non-stimulant series · Drug | ADHD | 50 | Drug · SMILES 확보 | |
| Med | Daridorexant Sleep / hypnotic series · Drug | Sleep · hypnotic | 50 | Drug · SMILES 확보 | |
| Med | Methylphenidate ADHD stimulant / non-stimulant series · Drug | ADHD | 50 | Drug · SMILES 확보 |
Drug · SMILES 확보 · Core 유사 81%
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보 · 중간 유사도
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
MedMedium exploration priority19
Mid-pool Exploration Score (X-B bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| Med | Suvorexant Sleep / hypnotic series · Drug | Sleep · hypnotic | 50 | Drug · SMILES 확보 | |
| Med | Olanzapine Atypical antipsychotic series · Drug | Antipsychotic | 49 | Drug · SMILES 확보 | |
| Med | Rasagiline Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 49 | Drug · SMILES 확보 | |
| Med | Ropinirole Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 49 | Drug · SMILES 확보 | |
| Med | Rotigotine Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 49 | Drug · SMILES 확보 | |
| Med | Selegiline Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 49 | Drug · SMILES 확보 | |
| Med | Eszopiclone Sleep / hypnotic series · Drug | Sleep · hypnotic | 48 | Drug · SMILES 확보 | |
| Med | Fluoxetine SSRI / SNRI antidepressant series · Drug | Antidepressant · SSRI/SNRI | 48 | Drug · SMILES 확보 | |
| Med | Fluvoxamine SSRI / SNRI antidepressant series · Drug | Antidepressant · SSRI/SNRI | 48 | Drug · SMILES 확보 | |
| Med | Lemborexant Sleep / hypnotic series · Drug | Sleep · hypnotic | 48 | Drug · SMILES 확보 | |
| Med | Aripiprazole Atypical antipsychotic series · Drug | Antipsychotic | 47 | Drug · SMILES 확보 | |
| Med | Gabapentin Neuropathic gabapentinoid / SNRI series · Drug | Neuropathic · gabapentinoid | 47 | Drug · SMILES 확보 | |
| Med | Pregabalin Neuropathic gabapentinoid / SNRI series · Drug | Neuropathic · gabapentinoid | 47 | Drug · SMILES 확보 | |
| Med | Entacapone Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 42 | Drug · SMILES 확보 | |
| Med | Pramipexole Parkinson dopaminergic / MAO-B series · Drug | Parkinson | 42 | Drug · SMILES 확보 | |
| Med | Escitalopram SSRI / SNRI antidepressant series · Drug | Antidepressant · SSRI/SNRI | 41 | Drug · SMILES 확보 | |
| Med | Guanfacine ADHD stimulant / non-stimulant series · Drug | ADHD | 41 | Drug · SMILES 확보 | |
| Med | Paroxetine SSRI / SNRI antidepressant series · Drug | Antidepressant · SSRI/SNRI | 41 | Drug · SMILES 확보 | |
| Med | Sertraline SSRI / SNRI antidepressant series · Drug | Antidepressant · SSRI/SNRI | 41 | Drug · SMILES 확보 |
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
LowLow exploration priority26
Lower Exploration Score — still listed for inspection (X-C bin)
| High exploration priority | 2D | Structure | Class | Exploration Score | Factors |
|---|---|---|---|---|---|
| Low | Venlafaxine SSRI / SNRI antidepressant series · Drug | Antidepressant · SSRI/SNRI | 41 | Drug · SMILES 확보 | |
| Low | Viloxazine ADHD stimulant / non-stimulant series · Drug | ADHD | 41 | Drug · SMILES 확보 | |
| Low | Zaleplon Sleep / hypnotic series · Drug | Sleep · hypnotic | 41 | Drug · SMILES 확보 | |
| Low | Zolpidem Sleep / hypnotic series · Drug | Sleep · hypnotic | 41 | Drug · SMILES 확보 | |
| Low | Carbamazepine Antiepileptic drug chemical series · Drug | Antiepileptic · AED | 40 | Drug · SMILES 확보 | |
| Low | Donepezil Cognitive modulator series · Drug | Cognition · dementia | 40 | Drug · SMILES 확보 | |
| Low | Duloxetine Neuropathic gabapentinoid / SNRI series · Drug | Neuropathic · gabapentinoid | 40 | Drug · SMILES 확보 | |
| Low | Edaravone ALS neuroprotectant series · Drug | ALS | 40 | Drug · SMILES 확보 | |
| Low | Fingolimod MS S1P modulator series · Drug | MS · S1P | 40 | Drug · SMILES 확보 | |
| Low | Galantamine Cognitive modulator series · Drug | Cognition · dementia | 40 | Drug · SMILES 확보 | |
| Low | Lamotrigine Antiepileptic drug chemical series · Drug | Antiepileptic · AED | 40 | Drug · SMILES 확보 | |
| Low | Levetiracetam Antiepileptic drug chemical series · Drug | Antiepileptic · AED | 40 | Drug · SMILES 확보 | |
| Low | Memantine Cognitive modulator series · Drug | Cognition · dementia | 40 | Drug · SMILES 확보 | |
| Low | Milnacipran Neuropathic gabapentinoid / SNRI series · Drug | Neuropathic · gabapentinoid | 40 | Drug · SMILES 확보 | |
| Low | Ozanimod MS S1P modulator series · Drug | MS · S1P | 40 | Drug · SMILES 확보 | |
| Low | Ponesimod MS S1P modulator series · Drug | MS · S1P | 40 | Drug · SMILES 확보 | |
| Low | Riluzole ALS neuroprotectant series · Drug | ALS | 40 | Drug · SMILES 확보 | |
| Low | Risperidone Atypical antipsychotic series · Drug | Antipsychotic | 40 | Drug · SMILES 확보 | |
| Low | Rivastigmine Cognitive modulator series · Drug | Cognition · dementia | 40 | Drug · SMILES 확보 | |
| Low | Siponimod MS S1P modulator series · Drug | MS · S1P | 40 | Drug · SMILES 확보 | |
| Low | Sodium phenylbutyrate ALS neuroprotectant series · Drug | ALS | 40 | Drug · SMILES 확보 | |
| Low | Tapentadol Neuropathic gabapentinoid / SNRI series · Drug | Neuropathic · gabapentinoid | 40 | Drug · SMILES 확보 | |
| Low | Taurursodiol ALS neuroprotectant series · Drug | ALS | 40 | Drug · SMILES 확보 | |
| Low | Topiramate Antiepileptic drug chemical series · Drug | Antiepileptic · AED | 40 | Drug · SMILES 확보 | |
| Low | Valproic acid Antiepileptic drug chemical series · Drug | Antiepileptic · AED | 40 | Drug · SMILES 확보 | |
| Low | Rimegepant CGRP gepant migraine series · Drug | Migraine · CGRP gepant | 39 | Drug · SMILES 확보 |
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Drug · SMILES 확보
Actual weights, formula and input limits
Exploration score method
StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.
Core tab
- scaffold / payload / linker role weights
- family center-compound bonus
- SMILES source (db · known · pubchem · inherited)
- relation-edge count and derived-child count
Derivative tab
- drug / derivative / adc candidates
- similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
- Approval, clinical and lead tag bonuses have been removed.
Explore tab
- sparse SAR, cross-scaffold pairs, expansion leaves
- weakly linked nodes and catalog-coverage gaps
- relation graph + stored Morgan fingerprints
- category filters
Exploration-priority bins
- High (X-S): top ~12%
- Medium (X-A/X-B): ~12–62%
- Low (X-C): remainder (pools under 5 compounds stay Medium)
Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.
평가 시각: 2026. 10. 28. 오후 7:56:17 · 캐시 5분 · 전체 패밀리